Alpa Laboratories share news and announcements
NSE: ALPABSE: 532878Pharmaceuticals & BiotechnologySmall Cap
Last close ₹49.29down ₹2.17 (4.22%)BSE ₹49.47
Share price at the NSE close on 23 Oct 2026. Previous close ₹51.46.
52-week range of traded prices to 23 Oct 2026
₹46.10Low, 30 Mar 2026₹93.85High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹104 Cr2,659th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 Jul 2026
- 0.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 23 Jul 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 14,17675.0% delivered
Alpa Laboratories board meetings
96 filed, newest first. Page 2 of 2.
Feb 2018
Dec 2017
15 Dec · Board meeting
Nov 2017
Aug 2017
31 Aug · Board meeting
10 Aug · Board meeting
Jul 2017
May 2017
Jan 2017
Nov 2016
Aug 2016
Jul 2016
May 2016
Apr 2016
Feb 2016
4 Feb · Board meeting
To consider and approve the financial results for the quarter and period ended 31st December 2015 along with other routine business.
Oct 2015
Jul 2015
May 2015
Feb 2015
3 Feb · Board meeting
To consider and approve the financial results for the quarter and period ended December 31, 2014 along with other routine business.
Nov 2014
7 Nov · Board meeting
To consider and approve the financial results for the quarter and period ended September 30, 2014 along with other routine business.
Jul 2014
31 Jul · Board meeting
To consider and approve the financial results for the quarter and period ended June 30, 2014 along with other routine business. Further, in terms of the Code for Corporate Disclosure Practices and Code of Conduct for prevention of Insider Trading pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 adopted by the Company, the Company has informed all the "concerned persons" that the Trading Window of the Company will be closed for Directors/ Empolyees from July 31, 2014 to Aug 09, 2014 (both days inclusive) in connection with the Company's Board Meeting as schedule above.
May 2014
20 May · Board meeting
To consider and approve the financial results for the quarter and period ended March 31, 2014 along with other routine business. Further, in terms of the Code for Corporate Disclosure Practices and Code of Conduct for Prevention of Insider Trading pursuant to the provisions of Securities and Exchange Board of India ( Prohibition of Insider Trading) Regulation s, 1992 adopted by the Company, the Company has informed all the "concerned persons" that the Trading Window of the Company will be closed for Directors/ Employees from May 20, 2014 to May 31, 2014 (both days inclusive) in connection with the Company" s Board Meeting as scheduled above.
Feb 2014
3 Feb · Board meeting
To consider and approve the financial results for the quarter and period ended December 31, 2013 along with other routine business.
Nov 2013
6 Nov · Board meeting
To consider and approve the financial results for the quarter and period ended September 30, 2013 along with other routine business.
Aug 2013
May 2013
21 May · Board meeting
To consider and approve the financial results for the quarter and period ended March 31, 2013 along with other routine business.
Feb 2013
6 Feb · Board meeting
To consider and approve the financial results for the quarter and period ended December 31, 2012 along with other routine business.
Nov 2012
2 Nov · Board meeting
To consider and approve the financial results for the quarter and period ended September 30, 2012 along with other routine business.
Aug 2012
3 Aug · Board meeting
To consider and approve the financial results for the quarter and period ended on June 30, 2012 along with other routine business.
May 2012
18 May · Board meeting
To consider and approve the financial results for the quarter and period ended March 31, 2012 along with other routine business.
Feb 2012
7 Feb · Board meeting
To consider and approve the financial results for the quarter ended December 31, 2011 along with other routine business.
Nov 2011
7 Nov · Board meeting
To consider and approve the financial results for the quarter and period ended September 30, 2011 along with other routine business.
Aug 2011
1 Aug · Board meeting
To consider and approve the financial results for the quarter and period ended June 30, 2011 along with other routine business.
May 2011
19 May · Board meeting
To consider and approve the financial results for the quarter and period ended March 31, 2011 along with other routine business.
Jan 2011
24 Jan · Board meeting
To consider and approve the financial results for the quarter and period ended December 31, 2010 along with other routine business.
Oct 2010
21 Oct · Board meeting
To consider and approve the financial results for the quarter and period ended September 30, 2010 along with other routine business.
Jul 2010
22 Jul · Board meeting
To consider and approve the financial results for the quarter and period ended June 30, 2010 along with other routine business.
Jan 2010
19 Jan · Board meeting
To consider and approve the unaudited financial results for the quarter ended December 31, 2009 along with other routine business.
Oct 2009
21 Oct · Board meeting
To consider and approve the unaudited financial results for the quarter ended September 30, 2009 along with other routine business.
Jul 2009
16 Jul · Board meeting
To consider and approve the unaudited financial results for the quarter ended June 30, 2009 along with other routine business.
May 2009
18 May · Board meeting
To consider and approve the audited financial results for the quarter and year ended March 31, 2009 along with other routine business.
Jan 2009
19 Jan · Board meeting
To consider and approve the unaudited financial results for the quarter ended December 31, 2008 along with other routine business.
Jul 2008
18 Jul · Board meeting
To consider and approve the unaudited financial results for the quarter ended June 30, 2008 along with other routine business.
Apr 2008
21 Apr · Board meeting
To consider and approve the un-audited financial results for the quarter ended March 31, 2008 along with other routine business.
Jan 2008
23 Jan · Board meeting
To consider and approve the un-audited financial Results for the quarter ended December 31, 2007 along with other routine business.
Oct 2007
25 Oct · Board meeting
To consider and approve the un audited financial Results for the quarter /half year ended September 30, 2007 along with other routine business.